Avalon Trust Co Has $15.62 Million Holdings in Danaher Corporation $DHR

Avalon Trust Co increased its holdings in Danaher Corporation (NYSE:DHR) by 5.1% in the third quarter, HoldingsChannel reports. The firm owned 78,807 shares of the conglomerate’s stock after purchasing an additional 3,847 shares during the period. Danaher accounts for approximately 1.0% of Avalon Trust Co’s portfolio, making the stock its 26th biggest holding. Avalon Trust Co’s holdings in Danaher were worth $15,624,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Sivia Capital Partners LLC raised its stake in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after acquiring an additional 119 shares in the last quarter. Carnegie Investment Counsel grew its holdings in Danaher by 8.6% during the second quarter. Carnegie Investment Counsel now owns 7,501 shares of the conglomerate’s stock valued at $1,482,000 after purchasing an additional 591 shares during the last quarter. Kornitzer Capital Management Inc. KS grew its holdings in Danaher by 1.0% during the second quarter. Kornitzer Capital Management Inc. KS now owns 9,746 shares of the conglomerate’s stock valued at $1,925,000 after purchasing an additional 95 shares during the last quarter. Linden Thomas Advisory Services LLC bought a new position in shares of Danaher in the second quarter valued at approximately $252,000. Finally, Stegent Equity Advisors Inc. lifted its stake in shares of Danaher by 60.5% in the second quarter. Stegent Equity Advisors Inc. now owns 1,764 shares of the conglomerate’s stock worth $348,000 after buying an additional 665 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Down 0.8%

NYSE DHR opened at $209.56 on Monday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $242.80. The stock has a market cap of $148.02 billion, a PE ratio of 41.58, a PEG ratio of 2.83 and a beta of 0.91. The firm has a 50-day simple moving average of $226.85 and a 200 day simple moving average of $216.03. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating the consensus estimate of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter in the prior year, the firm posted $2.14 EPS. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. On average, research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is 25.40%.

Insiders Place Their Bets

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of research analyst reports. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Monday, December 29th. Jefferies Financial Group lifted their price objective on Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. HSBC increased their target price on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research note on Monday, December 1st. Finally, Evercore reaffirmed an “outperform” rating and issued a $254.00 target price on shares of Danaher in a report on Wednesday, January 28th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.